This year, investors have focused on the rapid rise of biotech companies that have signed up with LSD, especially as such previously controversial chemicals have once again become the focus of attention on camera, selling the benefits of mental health. and then unite lawmakers in the U.S. House of Representatives beyond Democratic boundaries.

Others in this category are likely to make very large legal and regulatory profits in 2023, but because of the US government's built-in checks and balances, even the agreed US Congress cannot independently jeopardize the current drug policy.

In May 2022, Senator Corey Booker of the Democratic Party of Ohio and Senator Bobby Schatz of the Democratic Party of Hawaii jointly issued a letter imploring the Food and Drug Administration (FDA) of the Institute of Environmental Health of the National University abroad to study the main uses of LSD. By the end of the summer, US Democratic Congressman Seth Bill Gates of California and Dan Crenshaw of Texas also pledged to apply LSD research.

By 2012, FDA had created groundbreaking Therapy specific (BTD), which allows researchers to test other illegal drugs that are suspected of having unexplored medical benefits. MDMA won her first BTD title in 2017 and psilocybin in 2018. Oregon now allows psychiatrists to treat patients with psilocybin.

At a time when lawmakers of both parties are quarrelling over LSD in the federal government-- using his power to fund research-- such long-term and unlikely bipartisan alliances have inspired increasingly positive optimism among LSD companies and shareholders.

LSD in the U.S. Congress

However, it is not necessary to classify it as the "Aquarius period". In addition to the hidden healing benefits, strong support for veterans promotes collaboration around these drugs.

In July 2022, U.S. Congressman Alexandria Okacio-Cortez proposed an amendment to the 2023 Defense Authorization Act (NDAA) that requires the Secretary of Defense to work with poppies to study psilocybin and MDMA as a substitute for war with post-traumatic stress disorder, of which at least 6000 people will lose their lives in 2022 alone.

Dan Crenshaw, a veteran of the South China Sea Fleet and U.S. House of Representatives, proposed essentially the same amendment to NDAA, focusing on hallucinogens ibogaine and 5-MeO-DMT. "I think, to some extent, they are a kind of contractual cooperation amendment," Ocasio-Cortez told Bloomberg News. He confirmed that her office had communicated with Crenshaw's office.

Crenshaw previously expressed strong support for MDMA research in a panel discussion with Rick Doblin, chairman of the supervisory board of the Interdisciplinary Magic Research Institute (MDMA), and Jon Lubaki, a veteran who benefited from MDMA therapy, in August 2021.

Maps was the first pharmaceutical company to raise BTD for MDMA. The asset-rich MDMA jackfruit Equity Fund (PineApple Fund) donated $5 million and helped raise $4 million to support MAP's $26 million plan. In addition, the Crenshaw network voted to boycott the psychedelic drug law proposed by Okassio Cortez in 2019, which she proposed four days after the appearance of the working group in 2021.

When Crenshaw and Okassio Cortez jointly put forward his collaborative amendments this summer, the two amendments were based on a video-voice network vote shortly after they were submitted. Lubeki said that if AOC [Ocasio-Cortez] and Crenshaw can reach an agreement, it will be difficult to fight it. NDAA has long gained ground in the U.S. House of Representatives and is currently in debate in the House of Lords.

Seth Bill Gates, an American congressman who used to serve on the Armed Services Committee of the House of Representatives, proposed the same NDAA amendment as Okassio Cortez's amendment, which was silently destroyed.

In November 2022, US Congressman Lou Patricio of Florida and US Congressman Jason Bergman of Texas stepped up the stakes to establish the LSD Clinical observation (PACT) caucus meeting of the U.S. Congress. Patricio told Cointelegraph,PACT that it is a bipartisan Chinese think-tank that will explore "further research on how I, as the U.S. Congress, can apply clinical treatment." It is not easy for PACT to think that it is not a criminal case.

"during the Sacramento period, I met veterans who called for the use of poppies rather than prescription opioids to heal their visible and invisible wounds," Patricio recalls. "

During my time in poppy research, with more and more research, I have seen an unexpected change in journalistic professionalism. With the promising but still limited research on the clinical treatment of psychedelic drugs, it feels like a natural step. "

In the same month of the same year, Congressmen Booker and Rand Wade submitted the Promotion Therapy Act, which would change President Nixon's controllable Chemical substances Act, requiring the Drug Administration (DEA) to reclassify FDA to upgrade therapy designations for current and future treatments from Note 1 to Note 2. This is the first time since 1970 under the bill.

Wade told Cointelegraph that the move was aimed at "simplifying the registration process for groundbreaking therapies currently subject to outdated drug classification restrictions", adding that it would "make it easier for researchers to conduct research and get groundbreaking treatments to treat patients who are struggling with more serious and life-threatening conditions."

Leaders in the medical profession

Dr. Rachel Yehuda, a researcher at the James J. Lafarge Veterans Research Center on Mount Sinai, has studied post-traumatic stress disorder (PTSD) for more than 35 years. Since 2019, she has been studying the potential of LSD at the veteran level of clinical patients with the disease, although MDMA and psilocybin are still note 1 chemicals. In 2018, Yehuda met Doblin at Burning Man-just after FDA was awarded to MDMA BTD. Other pharmaceutical companies, including Compass Path and Usona Institute, encouraged by John Voight, have received BTD since then.

Yehuda added in an interview with Cointelegraph: "when I first heard of magic therapy, it was not just the use of psychedelic drugs that made me a little out of breath, and some people claimed that a treatment could make an unexpected difference."

"I have heard that many people's performance pledges will soon return to normal from post-traumatic stress disorder. It makes me a little angry because post-traumatic stress disorder is a very difficult disease to treat, especially among veterans.

However, Doblin invited Yehuda to participate in a week-long training in Africa, where clinicians watch and discuss short videos of MDMA treatment. "the people on the screen do remind me of veterans," she continued. "they look like them; they talk like them; they have the same problems-especially trauma and most things that make post-traumatic stress disorder untreatable. I said to Rick Doblin, 'Why don't you do this at the Veterans Administration?' "

The Department of Veterans Management (Department of Veterans Management) does not have an agreement to carry out such treatment on the premise of ensuring the security of multiple parties. It took a lot of hard work, but Yehuda used her theoretical knowledge and status to establish an agreement. Today, she is conducting a study in which 60 veterans are treated with MDMA over a period of three to eight hours of professionally guided treatment, while providing front and back care.

Further criticism

Livingston Ellenhorn and Scott Mughian County Molt, the founders of Cardera, a fantasy nursing home, recently stressed that other upper-conservative entities, such as the Yit and Mercer Charitable Foundation, had also cast hallucinogens, leading to bipartisan application for his research.

Ellenhorn and Mott of Mujian County write that some researchers are ideal for finding a scientific basis for the assumption that psychedelic drugs are likely to help end thorny issues of political conflict. They want to know whether this alliance of exploration and discovery will be as good as it seems. Psychedelic drugs can completely promote openness, but it can be open to Nazism, green eco-fascism or UFO cults, or it can be open to peace and love.

Arthur Kaplan and Kenneth Mohe, leading experts in microbiological ethics, have raised the question of whether the Enhancement Therapy Act can address the problem of postponement in groundbreaking therapy research, and whether it still makes more sense to work with FDA and DEA to manage methodological chemical timetables.

Can FDA itself undertake supervision and inspection to verify that the use and browsing of Note I trial drugs in clinical trials are controlled, or does DEA have to give second-level verification as note I normalizes psychoactive drugs in history? Asked the two men. "the first one is possible for us."

"the only long-term solution," Ehrenhorn and Mort in Mujian County went on, "is to directly address and deal with regulatory diversity, which increases costs and delays the timetable for potentially beneficial treatments."

It is worth noting that LSD alone does not eliminate depression, fear and trauma, because drugs cannot directly solve these symptoms.

The Center for LSD Science at the University of California, Berkeley, notes that although more and more states legalize LSD, these drugs are "still illegal within the federal government." so the impact of a new state law and regulation will be that the federal government refuses to sue for the substance. " For more than a century, Comanche Native Americans and religious leaders from Brazil have been leading the war between cadres and the House of Lords, which is still a stagnant area of poppy reform and innovation-looking for legal exemptions from the application of hallucinogens under religious acceptance.

Controlling picture quality is beneficial to the industry.

With the improvement of the law, as well as the high level of attention of due process and experts from different fields, LSD may receive a regulatory response that can help further expand the sales market.

Since 2018, the continuous growth of attention and the acceptance of capital investment in social development have helped magic stocks to rise sharply, and there have been some ups and downs. Although it is estimated that the compound annual growth rate of the entire market is expected to exceed 11.5% from 2021 to 2026 and will exceed $6.4 billion by 2028, the hot spot seems to peak in January 2021 and then gradually fall to an unexpected bottom from April 2022.

In this regard, the magical slash from a financial perspective echoes the historical ups and downs of the cryptocurrency market, especially in response to inconsistent laws and regulations based on decades of regulations of individual units. The decline in LSD inventory is related to the prediction of waiting for when it will be over. Crypto has been moving from the beginning.

Even so, many people in the password industry claim that the law will help the development of the password market, and 2023 will undoubtedly be the year when companies finally get a solid set of basic rules from due process.

But, on the whole, the fate of LSD is not just a tool for politics or profit. Whether we can get their healing ability or not is related to the situation of real people.

"many public health issues are beginning to become very divisive or polarized," Yehuda said. " "We can also encourage how we attach importance to the need for veterans to treat injuries after service programs in our country. And this is just the tip of a gradual iceberg, because there are a lot of people who can benefit from it. I believe we all have trauma and psychological problems.

"everyone is facing a good time," she concluded. " In order for this moment to continue, I hope there is a really careful way to work-if this treatment is as good as we think, it will be an important development for veterans' medical health and the development of medical health in our society.